Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Edward Kerwin, Gregory Feldman, James Pearle, Luis De La Cruz, Melinda Edwards, Carolyn Beaudot & George Georges. (2021) Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 181-190.
Read now
Read now
Maciej Kupczyk & Piotr Kuna. (2019) Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 13:1, pages 5-11.
Read now
Read now
Dave Singh. (2018) Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 19:11, pages 1279-1287.
Read now
Read now
Kai M Beeh, Aida Emirova, Hélène Prunier, Debora Santoro & Marie Anna Nandeuil. (2018) Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT). International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1701-1711.
Read now
Read now
Articles from other publishers (4)
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri & Nicola Scichilone. (2022) Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Crossref
M. Zysman, B. Ribeiro Baptista, T. Soumagne, V. Marques da Silva, C. Martin, C. Thibault de Menonville, L. Boyer, B. Degano, C. Morelot Panzini, P.R. Burgel, T. Perez, A. Bourdin, C. Raherison, H. Pégliasco, D. Piperno, C. Zanetti, H. Morel, B. Delclaux, C. Delafosse, A. Lorenzo, B. Housset, F. Chabot, P. Devillier, G. Deslée & N. Roche. (2021) Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021. Revue des Maladies Respiratoires 38:5, pages 539-561.
Crossref
Crossref
James Dean, Catalina Panainte, Naimat Khan & Dave Singh. (2020) The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD. Respiratory Research 21:1.
Crossref
Crossref
Dave Singh, Arjun Ravi, Katie Kane, Tess Schmalbach & David L. Hava. (2018) The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease. British Journal of Clinical Pharmacology 84:9, pages 2097-2105.
Crossref
Crossref